In some embodiments, a delivery device includes a device actuator and a cannula portion through which a therapeutic substance is ejected. The cannula portion includes an outer shaft, a needle that is configured to move through the outer shaft, and a plunger that is configured to move through the needle, forming a positive displacement arrangement.

An assembly for a drug delivery device comprises a housing, a dose member which is displaceable in a proximal direction with respect to the housing for setting of a dose of a drug, a clutch member which is displaced in the proximal direction with respect to the housing when setting the dose, and a stop member configured to define a clutch stop position. The clutch member and the dose member are configured to mechanically cooperate with one another when the clutch member is in the clutch stop position, thereby preventing further displacement of the dose member in the proximal direction with respect to the housing during setting of the dose.

An injection device comprises an actuator adapted when actuated to cause commencement of an injection sequence; a locking mechanism adapted to be moved between a locked position in which the locking mechanism prevents the actuator from being actuated, and an unlocked position in which the actuator can be actuated to cause commencement of the injection sequence. An indicator is configured to provide a visual indication of whether the locking mechanism is in its locked position or in its unlocked position.

An injector for ejecting an intraocular lens into an eye, comprises a longitudinal injector body, in which an injector piston rod can be guided in an axially displaceable manner, an injector nozzle at a front end of the injector body, in the direction of which the injector piston rod can be displaced, a displacement mechanism for pushing the injector piston rod forwards, and an actuating element for the manual actuation of the displacement mechanism. The displacement mechanism includes a transmission mechanism, by means of which the actuating element and the injector piston rod can be placed in an articulated driving connection, and an operating region for the actuation of the actuating element is formed at a longitudinal side of the injector body.

A gear-driven infusion assembly is provided which has a housing, a gear assembly coupled to the housing, a shuttle assembly slidably coupled to the housing and operably coupled to the gear assembly, and a tube enclosure connected to the housing. The tube enclosure is configured to house a primary drug closure. The gear assembly includes a spool assembly having a pinion gear and a drive spool. When the spring rotates the drive spool, the drive spool drives the pinion gear, and the gear assembly drives the shuttle assembly. When the gear assembly drives the shuttle assembly, the shuttle assembly slides longitudinally along the housing. The gear assembly may be spring driven such that a spring rotates the pinion gear about the drive spool. The primary drug closure may be a syringe. An overspeed protection device is also provided which has a spool assembly including a drive spool having a plurality of cams, a spring, and a pinion gear with spiral cam surfaces.

An injection device includes an elongated housing extending along a longitudinal axis and having a distal end and a proximal end, a dose tracker being at least one of translationally or rotationally displaceable relative to the housing and being displaceable between a zero dose positional state and a maximum dose positional state relative to the housing, the positional states indicating a dose, wherein one of the elongated housing and the dose tracker includes at least one tracking stop feature, and a preselector displaceable relative to the housing between at least two preselection positional states thereby defining the maximum dose positional state of the dose tracker, wherein the preselector includes at least one preselector stop feature configured to mechanically engage with the at least one tracking stop feature to block a displacement of the dose tracker beyond the maximum dose positional state.

An injecting device includes a housing having a longitudinal axis extending. A dose setting member is rotatable in the housing in a first or second direction about the longitudinal axis. A plunger extends through a bore of the dose setting member and into a bore of a barrel engaged with the housing. Pushing on an arm extending through a slot in the housing rotates the dose setting member in the first direction. As it rotates, indicia on the dose setting member are progressively displayed through an aperture in the housing. An actuator is engaged to release the dose setting member to rotate in the second direction and this rotation causes the plunger to move axially within the barrel's bore and push the pre-set dose of fluid therefrom. The dose setting member remains in a constant axial position within the housing during rotation in each of the first and second directions.

A medical device comprising a housing defining at least one enclosure for storing agent in a first form, a force applicator within the housing and adjacent the enclosure, a drive mechanism for moving the agent toward the force applicator, wherein the force applicator defines a surface for applying a force to the agent to separate the agent into particles smaller than a size of the first form, and wherein the device defines a lumen for receiving the particles from the force applicator and for receiving a pressurized fluid to propel the particles through the lumen.

Apparatus and methods for medicament delivery. The apparatus may include, and the methods may involve, a delivery device for delivering a target amount of the medicament from a distal end of the device. The device may include a rod for moving a plunger that discharges the medicament from the distal end. The device may avoid or reduce deformation of the plunger during the discharge. The plunger motion may be stopped by detent that interacts with the rod. The apparatus and the methods may provide an operator indication of progress of stages of operation. The device may feature triggers corresponding to stages of medicament displacement from the device, such as pre-delivery stages, including priming.

A new type of syringe for delivering composite material for direct application of the material in the mouth of a patient. The new type of syringe includes a threaded screw for driving a piston through the syringe in order to extrude the material from the end of the syringe. The extrusion force is thus generated in the syringe, thereby allowing for a simpler, less costly motorised driving system using a torque driving movement. The syringe also includes a localised heating arrangement at the extrusion end.